Clinical characteristics of the participants
| Variables | Total |
|---|---|
| (n=749) | |
| Age (years) | 50.2±10.6 |
| Body mass index (kg/m2) | 22.0±3.4 |
| Systolic blood pressure (mm Hg) | 121.1±19.0 |
| Diastolic blood pressure (mm Hg) | 73.9±12.4 |
| Heart rate (bpm) | 64.4±10.2 |
| Total cholesterol (mmol/L) | 5.37±0.88 |
| Triglycerides (mmol/L) | 1.07±0.71 |
| HDL-cholesterol (mmol/L) | 1.80±0.42 |
| LDL-cholesterol (mmol/L) | 3.11±0.77 |
| Glucose (mmol/L) | 5.32±1.47 |
| Uric acid (mg/dL) | 4.44±1.09 |
| eGFR (mL/min/1.73 m2) | 77.1±13.3 |
| Framingham risk score (%) | 3.94±3.62 |
| Hypertension (n (%)) | 112 (15.0) |
| Dyslipidemia (n (%)) | 262 (35.0) |
| Diabetes mellitus (n (%)) | 34 (4.5) |
| Smoking (n (%)) | 59 (7.9) |
| Metabolic syndrome (n (%)) | 65 (8.7) |
| Chronic kidney disease (n (%)) | 56 (8.4) |
| Menopause (n (%)) | 381 (50.9) |
| Flow-mediated vasodilation (%) | 6.59±3.60 |
| Baseline brachial artery diameter (mm) | 3.40±0.47 |
eGFR, estimated-glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein.